Table 1 Characteristics of study group (n = 104)
n (%) | |
|---|---|
Gender | 104 (100) |
Male | 76 (73.1) |
Female | 28 (26.9) |
Age | 103 (100) |
Minimum | 35 |
Maximum | 82 |
Median | 63 |
< 50 | 8 (7.7) |
50–59 | 29 (28.1) |
60–69 | 36 (34.9) |
70 + | 30 (29.1) |
Years from diagnosis | 104 (100) |
Current year (2020) | 2 (1.9) |
Last year (2019) | 11 (10.6) |
2–5 years (2018–2015) | 37 (35.6) |
6–10 years (2014–2010) | 31 (29.8) |
> 10 years | 23 (21.1) |
Diagnosis of metastatic disease | 104 (100) |
With RCC diagnosis | 24 (23.1) |
Within 1 year | 31 (29.8) |
1–5 years from RCC diagnosis | 25 (24.0) |
6–10 years from RCC diagnosis | 9 (8.7) |
> 10 years from RCC diagnosis | 15 (14.4) |